Patents by Inventor Dorit Marco

Dorit Marco has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12133919
    Abstract: The present application is directed to stabilized core-shell microcapsules comprising a core of benzoyl peroxide (BPO) or all trans retinoic acid (ATRA) and a metal-oxide shell; and to pharmaceutical compositions and methods of use thereof.
    Type: Grant
    Filed: May 23, 2021
    Date of Patent: November 5, 2024
    Assignee: Sol-Gel Technologies Ltd.
    Inventors: Ofer Toledano, Karine Neimann, Danil Finkel-Moiseev, Maya Erlich, Dorit Marco
  • Patent number: 12070629
    Abstract: The present invention provides core-stabilized microcapsules, wherein said core comprises at least one active agent encapsulated within an inorganic oxide shell, processes for their preparations, comparisons comprising them and uses thereof.
    Type: Grant
    Filed: June 7, 2021
    Date of Patent: August 27, 2024
    Assignee: Sol-Gel Technologies Ltd.
    Inventors: Ofer Toledano, Haim Bar-Simantov, Hanan Sertchook, Sharon Fireman-Shoresh, Dorit Marco
  • Publication number: 20230338306
    Abstract: The present application is directed to stabilized core-shell microcapsules comprising a core of benzoyl peroxide (BPO) or all trans retinoic acid (ATRA) and a metal-oxide shell; and to pharmaceutical compositions and methods of use thereof.
    Type: Application
    Filed: March 30, 2023
    Publication date: October 26, 2023
    Applicant: Sol-Gel Technologies Ltd.
    Inventors: Ofer TOLEDANO, Karine NEIMANN, Danil FINKEL-MOISEEV, Maya ERLICH, Dorit MARCO
  • Publication number: 20210361586
    Abstract: The present application is directed to stabilized core-shell microcapsules comprising a core of benzoyl peroxide (BPO) or all trans retinoic acid (ATRA) and a metal-oxide shell; and to pharmaceutical compositions and methods of use thereof.
    Type: Application
    Filed: May 23, 2021
    Publication date: November 25, 2021
    Applicant: Sol-Gel Technologies Ltd.
    Inventors: Ofer Toledano, Karine Neimann, Danil Finkel-Moiseev, Maya Erlich, Dorit MARCO
  • Publication number: 20210361608
    Abstract: The present application is directed to stabilized core-shell microcapsules comprising a core of benzoyl peroxide (BPO) or all trans retinoic acid (ATRA) and a metal-oxide shell; and to pharmaceutical compositions and methods of use thereof.
    Type: Application
    Filed: May 23, 2021
    Publication date: November 25, 2021
    Applicant: Sol-Gel Technologies Ltd.
    Inventors: Ofer TOLEDANO, Karine NEIMANN, Danil FINKEL-MOISEEV, Maya ERLICH, Dorit MARCO
  • Publication number: 20210361583
    Abstract: The present application is directed to stabilized core-shell microcapsules comprising a core of benzoyl peroxide (BPO) or all trans retinoic acid (ATRA) and a metal-oxide shell; and to pharmaceutical compositions and methods of use thereof.
    Type: Application
    Filed: May 23, 2021
    Publication date: November 25, 2021
    Applicant: Sol-Gel Technologies Ltd.
    Inventors: Ofer TOLEDANO, Karine NEIMANN, Danil FINKEL-MOISEEV, Maya ERLICH, Dorit MARCO
  • Publication number: 20210290985
    Abstract: The present invention provides core-stabilized microcapsules, wherein said core comprises at least one active agent encapsulated within an inorganic oxide shell, processes for their preparations, comparisons comprising them and uses thereof.
    Type: Application
    Filed: June 7, 2021
    Publication date: September 23, 2021
    Applicant: Sol-Gel Technologies Ltd.
    Inventors: Ofer Toledano, Haim Bar-Simantov, Hanan Sertchook, Sharon Fireman-Shoresh, Dorit Marco
  • Patent number: 11071878
    Abstract: The present invention provides core-stabilized microcapsules, wherein said core comprises at least one active agent encapsulated within an inorganic oxide shell, processes for their preparations, comparisons comprising them and uses thereof.
    Type: Grant
    Filed: March 19, 2018
    Date of Patent: July 27, 2021
    Assignee: Sol-Gel Technologies Ltd.
    Inventors: Ofer Toledano, Haim Bar-Simantov, Hanan Sertchook, Sharon Fireman-Shoresh, Dorit Marco
  • Patent number: 10653899
    Abstract: The present invention provides core-stabilized microcapsules, wherein said core comprises at least one active agent encapsulated within an inorganic oxide shell, processes for their preparations, comparisons comprising them and uses thereof.
    Type: Grant
    Filed: August 2, 2018
    Date of Patent: May 19, 2020
    Assignee: SOL-GEL TECHNOLOGIES LTD.
    Inventors: Ofer Toledano, Haim Bar-Simantov, Hanan Sertchook, Sharon Fireman-Shoresh, Dorit Marco
  • Patent number: 10512796
    Abstract: The present invention provides core-stabilized microcapsules, wherein said core comprises at least one active agent encapsulated within a metal oxide shell, processes for their preparations, comparisons comprising them and uses thereof.
    Type: Grant
    Filed: December 30, 2010
    Date of Patent: December 24, 2019
    Assignee: SOL-GEL TECHNOLOGIES LTD.
    Inventors: Ofer Toledano, Haim Bar-Simantov, Hanan Sertchook, Sharon Fireman-Shoresh, Dorit Marco-Dagan
  • Publication number: 20190015366
    Abstract: The present application is directed to compositions comprising microcapsules comprising encapsulated tretinoin, wherein the microcapsule size is less than 50 ?m; and to methods of use thereof.
    Type: Application
    Filed: July 12, 2018
    Publication date: January 17, 2019
    Applicant: SOL-GEL TECHNOLOGIES LTD.
    Inventors: Ofer TOLEDANO, Karine Neimann, Maya Erlich, Dorit Marco
  • Publication number: 20180339176
    Abstract: The present invention provides core-stabilized microcapsules, wherein said core comprises at least one active agent encapsulated within an inorganic oxide shell, processes for their preparations, comparisons comprising them and uses thereof.
    Type: Application
    Filed: August 2, 2018
    Publication date: November 29, 2018
    Applicant: SOL-GEL TECHNOLOGIES LTD.
    Inventors: Ofer TOLEDANO, Haim BAR-SIMANTOV, Hanan SERTCHOOK, Sharon FIREMAN-SHORESH, Dorit MARCO
  • Publication number: 20180207451
    Abstract: The present invention provides core-stabilized microcapsules, wherein said core comprises at least one active agent encapsulated within a inorganic oxide shell, processes for their preparations, comparisons comprising them and uses thereof.
    Type: Application
    Filed: March 19, 2018
    Publication date: July 26, 2018
    Applicant: SOL-GEL TECHNOLOGIES LTD.
    Inventors: Ofer TOLEDANO, Haim BAR-SIMANTOV, Hanan SERTCHOOK, Sharon FIREMAN-SHORESH, Dorit MARCO
  • Publication number: 20180117369
    Abstract: The present invention provides core-stabilized microcapsules, wherein said core comprises at least one active agent encapsulated within a metal oxide shell, processes for their preparations, comparisons comprising them and uses thereof.
    Type: Application
    Filed: December 7, 2017
    Publication date: May 3, 2018
    Applicant: SOL-GEL TECHNOLOGIES LTD.
    Inventors: Ofer Toledano, Haim Bar-Simantov, Hanan Sertchook, Sharon Fireman-Shoresh, Dorit Marco
  • Patent number: 8597666
    Abstract: A pharmaceutical formulation of compounds with low aqueous solubility and method of manufacture thereof. The formulation may include a pharmacologically active compound having low aqueous solubility and starch in the amount of greater than about 25 weight percent. A manufacturing method may include blending the active compound and starch, compressing the blend into a solid, comminuting the solid into granules, wetting the granules, drying the granules, and tabletting the dried granules to make a solid pharmaceutical formulation.
    Type: Grant
    Filed: October 28, 2011
    Date of Patent: December 3, 2013
    Assignee: Teva Pharmaceutical Industries, Ltd.
    Inventors: Ilan Zalit, Fanny Leska, Mali Kadosh, Dorit Marco, Yonit Messer-Triger
  • Patent number: 8367105
    Abstract: A pharmaceutical formulation of compounds with low aqueous solubility and method of manufacture thereof. The formulation may include a pharmacologically active compound having low aqueous solubility and starch in the amount of greater than about 25 weight percent. A manufacturing method may include blending the active compound and starch, compressing the blend into a solid, comminuting the solid into granules, wetting the granules, drying the granules, and tabletting the dried granules to make a solid pharmaceutical formulation.
    Type: Grant
    Filed: November 10, 2004
    Date of Patent: February 5, 2013
    Assignee: Teva Pharmaceutical Industries, Ltd.
    Inventors: Ilan Zalit, Fanny Leska, Mali Kadosh, Dorit Marco, Yonit Messer-Triger
  • Patent number: 8367106
    Abstract: A pharmaceutical formulation of compounds with low aqueous solubility and method of manufacture thereof. The formulation may include a pharmacologically active compound having low aqueous solubility and starch in the amount of greater than about 25 weight percent. A manufacturing method may include blending the active compound and starch, compressing the blend into a solid, comminuting the solid into granules, wetting the granules, drying the granules, and tabletting the dried granules to make a solid pharmaceutical formulation.
    Type: Grant
    Filed: July 7, 2006
    Date of Patent: February 5, 2013
    Assignee: Teva Pharmaceutical Industries, Ltd.
    Inventors: Ilan Zalit, Fanny Leska, Mali Kadosh, Dorit Marco, Yonit Messer-Triger
  • Publication number: 20120202695
    Abstract: The present invention provides core-stabilized microcapsules, wherein said core comprises at least one active agent encapsulated within a metal oxide shell, processes for their preparations, comparisons comprising them and uses thereof.
    Type: Application
    Filed: December 30, 2010
    Publication date: August 9, 2012
    Applicant: SOL-GEL TECHNOLOGIES LTD.
    Inventors: Ofer Toledano, Haim Bar-Simantov, Hanan Sertchook, Sharon Fireman-Shoresh, Dorit Marco-Dagan
  • Publication number: 20120045488
    Abstract: A pharmaceutical formulation of compounds with low aqueous solubility and method of manufacture thereof. The formulation may include a pharmacologically active compound having low aqueous solubility and starch in the amount of greater than about 25 weight percent. A manufacturing method may include blending the active compound and starch, compressing the blend into a solid, comminuting the solid into granules, wetting the granules, drying the granules, and tabletting the dried granules to make a solid pharmaceutical formulation.
    Type: Application
    Filed: October 28, 2011
    Publication date: February 23, 2012
    Inventors: Ilan Zalit, Fanny Leska, Mali Kadosh, Dorit Marco, Yonit Messer-Triger
  • Publication number: 20060251718
    Abstract: A pharmaceutical formulation of compounds with low aqueous solubility and method of manufacture thereof. The formulation may include a pharmacologically active compound having low aqueous solubility and starch in the amount of greater than about 25 weight percent. A manufacturing method may include blending the active compound and starch, compressing the blend into a solid, comminuting the solid into granules, wetting the granules, drying the granules, and tabletting the dried granules to make a solid pharmaceutical formulation.
    Type: Application
    Filed: July 7, 2006
    Publication date: November 9, 2006
    Inventors: Ilan Zalit, Fanny Leska, Mali Kadosh, Dorit Marco, Yonit Messer-Triger